IPR THERAPY
ResQCPR System
The ResQCPR™ System is a CPR adjunct that consists of two synergistic devices—the ResQPOD® ITD 16 and the ResQPUMP® ACD-CPR device. Together, they increase the likelihood of survival. A major clinical study of more than 1600 patients showed a 49% increase in one-year survival from cardiac arrest.*
- The ResQPOD ITD 16 returns more blood to the heart (preload) and lowers intracranial pressure by regulating airflow during CPR to increase the vacuum in a patient’s chest during chest wall recoil.1,2
- The ResQPUMP ACD-CPR device further increases blood return by re-expanding the chest with a lift force of up to 10 kg. It is the only approved system for delivering true active compression-decompression CPR.
ResQGARD ITD
The ResQGARD® is an impedance threshold device (ITD) that provides a rapid, safe, and noninvasive way to improve perfusion in spontaneously breathing hypotensive patients. The ResQGARD provides therapeutic benefit as soon as a patient begins to breathe through it, and it is easy to discontinue (“ON/OFF” therapy). The ResQGARD increases blood pressure during hypotension from a variety of causes,1-6 for example:
- Early sepsis
- Orthostatic intolerance
- Trauma/hypovolemia
- Heat shock
- Dialysis
- Blood donation
Clinical and pre-clinical studies have shown that the ResQGARD ITD:
- Increases systolic and diastolic blood pressure by up to 30%1
- Improves cerebral blood flow2
- Increases blood pressure in hypovolemic hypotension but not to levels typically associated with "popping the clot"3
ResQPOD ITD
Enhanced Perfusion During High-Quality CPR
The ResQPOD® impedance threshold device (ITD) is a simple, non-invasive device that delivers intrathoracic pressure regulation (IPR) therapy during basic or advanced life support CPR to improve perfusion. The ResQPOD lowers intrathoracic pressure during the recoil phase of CPR by selectively restricting unnecessary airflow into the chest. This vacuum increases preload, lowers intracranial pressure (ICP), and improves blood flow to the brain and vital organs.
Improved Outcomes
Studies have shown that when combined with high-quality CPR, the ResQPOD ITD:
- Doubles blood flow to the heart1
- Increases blood flow to the brain by 50%2
- Increases survival from cardiac arrest by 25% or more3